620598-08-5

Basic information

• Product Name: 7-benzyloxy-3,4-dihydro-2H-quinoline-1-carboxylic acid benzyl ester-4-spiro-5'-3'-(1-tert-butoxycarbonyl-1H-indol-3-ylmethyl)-imidazolidine-2',4'-dione
• Synonyms: 7-benzyloxy-3,4-dihydro-2H-quinoline-1-carboxylic acid benzyl ester-4-spiro-5'-3'-(1-tert-butoxycarbonyl-1H-indol-3-ylmethyl)-imidazolidine-2',4'-dione
• CAS NO: 620598-08-5
• Molecular Weight: 686.764
• Mol File: 620598-08-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 7-benzyloxy-3,4-dihydro-2H-quinoline-1-carboxylic acid benzyl ester-4-spiro-5'-3'-(1-tert-butoxycarbonyl-1H-indol-3-ylmethyl)-imidazolidine-2',4'-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 7-benzyloxy-3,4-dihydro-2H-quinoline-1-carboxylic acid benzyl ester-4-spiro-5'-3'-(1-tert-butoxycarbonyl-1H-indol-3-ylmethyl)-imidazolidine-2',4'-dione(620598-08-5)
• EPA Substance Registry System: 7-benzyloxy-3,4-dihydro-2H-quinoline-1-carboxylic acid benzyl ester-4-spiro-5'-3'-(1-tert-butoxycarbonyl-1H-indol-3-ylmethyl)-imidazolidine-2',4'-dione(620598-08-5)

Safety Data

• Hazardous Substances Data: 620598-08-5(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 620598-17-6 3-methanesulfonyloxymethyl-indole-1-carboxylic acid tert-butyl ester 
• 620598-05-2 7-benzyloxy-3,4-dihydro-2H-quinoline-1-carboxylic acid benzyl ester-4-spiro-5'-imidazolidine-2',4'-dione 
• 620598-02-9 1-benzyloxycarbonyl-7-benzyloxy-3,4-dihydro-2H-quinolin-4-one 
• 620597-98-0 N-(3-(benzyloxy)phenyl)-3-bromopropanamide 
• 620598-00-7 7-benzyloxy-2,3-dihydro-1H-quinolin-4-one 
• 96551-22-3 t-butyl 3-hydroxymethylindole-1-carboxylate 
• 76228-00-7 1-(3-benzyloxy-phenyl)-azetidin-2-one 
• 57476-50-3 1-tert-butoxycarbonyl-3-formylindole 
• 487-89-8 Indole-3-carboxaldehyde 

Downstream Products

• 651322-93-9 7-benzyloxy-3,4-dihydro-2H-quinoline-1-carboxylic acid benzyl ester-4-spiro-5'-3'-(1-tert-butoxycarbonylindol-3-ylmethyl)-1'-methyl-imidazolidine-2',4'-dione 

Relevant articles and documents

Somatostatin analogue compounds

Compounds having somatostatin activity of the following Formula I, 1wherein, R1 is aryl, substituted-aryl, and aryl-(lower-alkyl)-; R2 is lower alkyl, amino substituted lower alkyl, -carboxy-(lower-alkyl), -carbamic acid-(lower-alkyl) and -carboxy-(lower-alkyl)-aryl; and R3 and R4 are independently, lower-alkyl, aryl, substituted-aryl, (substituted-aryl)-(lower-alkyl)-, heteroaryl, (heteroaryl)-(lower-alkyl)-, substituted-heteroaryl, (substituted heteroaryl)-(lower-alkyl)-, heterocyclic, heterocyclic-(lower-alkyl)-, substituted-heterocyclic, (substituted-heterocylic)-(lower alkyl)-, -carboxy-(lower-alkyl), and -carboxy-(lower-alkyl)-aryl; or a pharmaceutically acceptable, ester, ether, or salt thereof; methods for their use; and preparation.